beta peptide immunization reduces behavioural impairment plaques model alzheimers disease 
much evidence indicates abnormal processing extracellular deposition amyloid-beta peptide beta proteolytic derivative beta amyloid precursor protein beta app central pathogenesis alzheimers disease reviewed ref pdapp transgenic mouse model alzheimers disease immunization ab causes marked reduction burden brain amyloid evidence beta immunization also reduces cognitive dysfunction murine models alzheimers disease support hypothesis abnormal beta processing essential pathogenesis alzheimers disease encourage development strategies directed amyloid cascade show beta immunization reduces deposition cerebral fibrillar beta cognitive dysfunction tgcrnd8 murine model alzheimers disease without however altering total levels beta brain implies either similar % reduction dense-cored beta plaques sufficient affect cognition vaccination may modulate activity/abundance small subpopulation especially toxic beta species 
